These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 8755558)
41. A mouse model for Prader-Willi syndrome imprinting-centre mutations. Yang T; Adamson TE; Resnick JL; Leff S; Wevrick R; Francke U; Jenkins NA; Copeland NG; Brannan CI Nat Genet; 1998 May; 19(1):25-31. PubMed ID: 9590284 [TBL] [Abstract][Full Text] [Related]
42. The imprinting mechanism of the Prader-Willi/Angelman regional control center. Perk J; Makedonski K; Lande L; Cedar H; Razin A; Shemer R EMBO J; 2002 Nov; 21(21):5807-14. PubMed ID: 12411498 [TBL] [Abstract][Full Text] [Related]
43. Imprinting center analysis in Prader-Willi and Angelman syndrome patients with typical and atypical phenotypes. Camprubí C; Coll MD; Villatoro S; Gabau E; Kamli A; Martínez MJ; Poyatos D; Guitart M Eur J Med Genet; 2007; 50(1):11-20. PubMed ID: 17095305 [TBL] [Abstract][Full Text] [Related]
44. A 5-kb imprinting center deletion in a family with Angelman syndrome reduces the shortest region of deletion overlap to 880 bp. Buiting K; Lich C; Cottrell S; Barnicoat A; Horsthemke B Hum Genet; 1999 Dec; 105(6):665-6. PubMed ID: 10647904 [TBL] [Abstract][Full Text] [Related]
45. A new deletion refines the boundaries of the murine Prader-Willi syndrome imprinting center. Dubose AJ; Smith EY; Yang TP; Johnstone KA; Resnick JL Hum Mol Genet; 2011 Sep; 20(17):3461-6. PubMed ID: 21659337 [TBL] [Abstract][Full Text] [Related]
46. Imprint switch mechanism indicated by mutations in Prader-Willi and Angelman syndromes. Kelsey G; Reik W Bioessays; 1997 May; 19(5):361-5. PubMed ID: 9174400 [TBL] [Abstract][Full Text] [Related]
47. The chromosome 15 imprinting centre (IC) region has undergone multiple duplication events and contains an upstream exon of SNRPN that is deleted in all Angelman syndrome patients with an IC microdeletion. Färber C; Dittrich B; Buiting K; Horsthemke B Hum Mol Genet; 1999 Feb; 8(2):337-43. PubMed ID: 9931342 [TBL] [Abstract][Full Text] [Related]
48. Prader-Willi syndrome: reflections on seminal studies and future therapies. Chung MS; Langouët M; Chamberlain SJ; Carmichael GG Open Biol; 2020 Sep; 10(9):200195. PubMed ID: 32961075 [TBL] [Abstract][Full Text] [Related]
49. DNA methylation analysis with respect to prenatal diagnosis of the Angelman and Prader-Willi syndromes and imprinting. Glenn CC; Deng G; Michaelis RC; Tarleton J; Phelan MC; Surh L; Yang TP; Driscoll DJ Prenat Diagn; 2000 Apr; 20(4):300-6. PubMed ID: 10740202 [TBL] [Abstract][Full Text] [Related]
50. Analysis of imprinted genes in subjects with Prader-Willi syndrome and chromosome 15 abnormalities. Muralidhar B; Marney A; Butler MG Genet Med; 1999; 1(4):141-5. PubMed ID: 11258349 [TBL] [Abstract][Full Text] [Related]
51. The genetic basis for Prader-Willi syndrome: the importance of imprinted genes. Brøndum-Nielsen K Acta Paediatr Suppl; 1997 Nov; 423():55-7. PubMed ID: 9401540 [TBL] [Abstract][Full Text] [Related]
52. Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Dittrich B; Buiting K; Korn B; Rickard S; Buxton J; Saitoh S; Nicholls RD; Poustka A; Winterpacht A; Zabel B; Horsthemke B Nat Genet; 1996 Oct; 14(2):163-70. PubMed ID: 8841186 [TBL] [Abstract][Full Text] [Related]
53. Prader-Willi syndrome and Angelman syndrome. Buiting K Am J Med Genet C Semin Med Genet; 2010 Aug; 154C(3):365-76. PubMed ID: 20803659 [TBL] [Abstract][Full Text] [Related]
54. Establishing the epigenetic status of the Prader-Willi/Angelman imprinting center in the gametes and embryo. Kantor B; Kaufman Y; Makedonski K; Razin A; Shemer R Hum Mol Genet; 2004 Nov; 13(22):2767-79. PubMed ID: 15367489 [TBL] [Abstract][Full Text] [Related]
55. Exploring the unique function of imprinting control centers in the PWS/AS-responsible region: finding from array-based methylation analysis in cases with variously sized microdeletions. Matsubara K; Itoh M; Shimizu K; Saito S; Enomoto K; Nakabayashi K; Hata K; Kurosawa K; Ogata T; Fukami M; Kagami M Clin Epigenetics; 2019 Feb; 11(1):36. PubMed ID: 30819260 [TBL] [Abstract][Full Text] [Related]
56. A mouse model of Angelman syndrome imprinting defects. Lewis MW; Vargas-Franco D; Morse DA; Resnick JL Hum Mol Genet; 2019 Jan; 28(2):220-229. PubMed ID: 30260400 [TBL] [Abstract][Full Text] [Related]
57. Identification of a silencing element in the human 15q11-q13 imprinting center by using transgenic Drosophila. Lyko F; Buiting K; Horsthemke B; Paro R Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1698-702. PubMed ID: 9465079 [TBL] [Abstract][Full Text] [Related]
58. Transcription is required to establish maternal imprinting at the Prader-Willi syndrome and Angelman syndrome locus. Smith EY; Futtner CR; Chamberlain SJ; Johnstone KA; Resnick JL PLoS Genet; 2011 Dec; 7(12):e1002422. PubMed ID: 22242001 [TBL] [Abstract][Full Text] [Related]
59. Prader-Willi syndrome and atypical submicroscopic 15q11-q13 deletions with or without imprinting defects. Hassan M; Butler MG Eur J Med Genet; 2016 Nov; 59(11):584-589. PubMed ID: 27659713 [TBL] [Abstract][Full Text] [Related]
60. A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and angelman syndromes. Gabriel JM; Merchant M; Ohta T; Ji Y; Caldwell RG; Ramsey MJ; Tucker JD; Longnecker R; Nicholls RD Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9258-63. PubMed ID: 10430930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]